Camrelizumab plus nab-paclitaxel in platinum-resistant patients with unresectable locally advanced or metastatic urothelial carcinoma: A multicentre, single-arm, phase II study

被引：1
|
作者：
Li, H. [1 ]
Chen, M. [1 ]
Xue, C. [2 ]
Li, L. [1 ]
Hu, A. [1 ]
Yang, W. [1 ]
Zheng, Z. [3 ]
Ni, M. [1 ]
Zhang, L. [1 ]
Zeng, Y. [1 ]
Peng, J. [1 ]
Yao, K. [4 ]
Zhou, F. [4 ]
Liu, Z. [4 ]
An, X. [1 ]
Shi, Y. [1 ]
机构：
[1] Sun Yat sen Univ, Med Oncol, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Med Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat sen Univ, 3 Med Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Urol, Canc Ctr, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1822
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1744P
引用
收藏
页码：S1335 / S1335
页数：1
相关论文
共 50 条
  • [1] A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
    Liu, Ting
    Li, Qing
    Lin, Zhen
    Liu, Chunhua
    Pu, Wei
    Zeng, Shasha
    Lai, Jun
    Cai, Xuebin
    Zhang, Lisha
    Wang, Shuyang
    Chen, Miao
    Cao, Wei
    Gou, Hongfeng
    Zhu, Qing
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 602 - 615
  • [2] Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study
    Giannatempo, P.
    Raggi, D.
    Marandino, L.
    Bandini, M.
    Fare, E.
    Calareso, G.
    Colecchia, M.
    Gallina, A.
    Ross, J. S.
    Alessi, A.
    Briganti, A.
    Montorsi, F.
    Madison, R.
    Necchi, A.
    ANNALS OF ONCOLOGY, 2020, 31 (12) : 1764 - 1772
  • [3] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
    Li, G.
    Zhao, Y.
    Jiang, Y.
    Yang, Q.
    Huang, A.
    Chen, Y.
    Han, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S753 - S754
  • [5] Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial
    Wang, Chengzheng
    Liu, Zhenzhen
    Chen, Xiuchun
    Qiao, Jianghua
    Lu, Zhenduo
    Li, Lianfang
    Sun, Xianfu
    Zhang, Chongjian
    Yue, Xiayu
    Xia, Qingxin
    Zhang, He
    Yan, Min
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [6] Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial
    Chengzheng Wang
    Zhenzhen Liu
    Xiuchun Chen
    Jianghua Qiao
    Zhenduo Lu
    Lianfang Li
    Xianfu Sun
    Chongjian Zhang
    Xiayu Yue
    Qingxin Xia
    He Zhang
    Min Yan
    Nature Communications, 14 (1)
  • [7] A phase II study of bevacizumab with nab-paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma
    Tillmanns, T. D.
    Lowe, M. P.
    Schwartzberg, L. S.
    Walker, M. S.
    Stepanski, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study
    Sheng, Yinliang
    Meng, Xiangrui
    Zhang, Chunyang
    Shan, Zhengzheng
    Li, Feng
    Wu, Bin
    Xu, Mengli
    Li, Aijia
    Guan, Lulu
    Chen, Lidong
    Sun, Shuzhen
    Ma, Yihui
    Lu, Taiying
    Zhao, Song
    Fan, Qingxia
    Qi, Yu
    Wang, Feng
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5337 - 5347
  • [9] Camrelizumab combined with anlotinib and nab-paclitaxel in patients with untreated advanced mucosal melanoma: A single-arm, multicenter, exploratory study.
    Wu, Di
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study
    Takano, Nao
    Yamada, Suguru
    Hirakawa, Akihiro
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Okada, Tohru
    Ohno, Eizaburo
    Yamaguchi, Junpei
    Ishikawa, Takuya
    Sonohara, Fuminori
    Suenaga, Masaya
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Fuji, Tsutomu
    Kodera, Yasuhiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2019, 81 (02): : 233 - 239
12345